The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CARIBOU BIOSCIENCES INC | COM | 142038108 | 5,001 | 474,067 | SH | DFND | 0 | 0 | 474,067 | 0 | |
| ENTRADA THERAPEUTICS INC | COM | 29384C108 | 8,022 | 509,023 | SH | DFND | 0 | 0 | 509,023 | 0 | |
| OMEGA THERAPEUTICS INC | COMMON STOCK | 68217N105 | 1,913 | 352,941 | SH | DFND | 0 | 0 | 352,941 | 0 | |
| PRAXIS PRECISION MEDICINES I | COM | 74006W108 | 2,245 | 988,995 | SH | DFND | 0 | 0 | 988,995 | 0 | |
| PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 109,052 | 1,848,024 | SH | DFND | 0 | 0 | 1,848,024 | 0 | |